INHIBITION OF HUMAN NEUTROPHIL ELASTASE .3. AN ORALLY-ACTIVE ENOL ACETATE PRODRUG

Citation
Jp. Burkhart et al., INHIBITION OF HUMAN NEUTROPHIL ELASTASE .3. AN ORALLY-ACTIVE ENOL ACETATE PRODRUG, Journal of medicinal chemistry, 38(2), 1995, pp. 223-233
Citations number
28
Categorie Soggetti
Chemistry Medicinal
ISSN journal
00222623
Volume
38
Issue
2
Year of publication
1995
Pages
223 - 233
Database
ISI
SICI code
0022-2623(1995)38:2<223:IOHNE.>2.0.ZU;2-Q
Abstract
Several analogs of fluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (1), in which the chiral center of the P-1 residue has been eliminated , were synthesized and tested as inhibitors of human neutrophil elasta se (HNE). Observations made during the course of this work led to the development of a single-step, stereoselective synthesis of E-enol acet ate derivatives from HNE inhibitors containing a mixture of epimers at P-1. In, vitro studies, in the presence of added esterase, and F-19 N MR studies, in biological media, indicated that the E-enol acetate der ivatives should act as prodrugs in vivo. The ED(50) value for afluoro- 1-(1-methylethyl)-1-butenyl]-L-prolinamide (20), when administered ora lly in the hamster lung hemorrhage model, was 9 mg/kg.